Head-to-head
Ivim Health vs HealthRX
Compared on both medications across the eight dimensions this database records. They differ on 7 of those eight. HealthRX is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Ivim Health is $353 a month all-in for tirzepatide; HealthRX is $209. Over twelve months that is $4,236 against $2,148. Value Scores are 46.3 and 82.1 out of 100.
Tirzepatide
Plan pages: Ivim Health plans · HealthRX plans
At 10 mg/week, Ivim Health is $353 a month all-in and HealthRX is $209 — $144 apart, or $1,728 across a year. Over twelve months the totals are $4,236 (billed monthly) and $2,148 (prepaid term).
Ivim Health prices tirzepatide by dose: $208 per month at 2.5 mg rising to $278 at 10 mg, a difference of $70 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
HealthRX charges a flat $209 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | Ivim Health | Rank | HealthRX | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $208 | 10/31 | $209 | 11/31 | Ivim Health by $1 |
| 5 mg | — | — | $209 | 5/17 | only HealthRX publishes |
| 7.5 mg | — | — | $209 | 5/17 | only HealthRX publishes |
| 10 mg | $278 | 7/27 | $209 | 5/27 | HealthRX by $69 |
| 12.5 mg | — | — | $209 | 5/17 | only HealthRX publishes |
| 15 mg | — | — | $209 | 5/17 | only HealthRX publishes |
The lead changes with the dose. Between 2.5 mg and 10 mg it passes to HealthRX. Pick on the dose you expect to settle at, not the headline.
Across the 27 programs this database can rank on tirzepatide, Ivim Health sits 16 of 27 on all-in monthly cost and HealthRX sits 5. There are 10 other programs priced between them. The field median is $339 and the floor is $169, so HealthRX is below the median and the other is above it. Ivim Health is $184 above the cheapest tirzepatide program on record. HealthRX is $40 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Ivim Health undercuts it by $96, HealthRX by $240. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Ivim Health | HealthRX | Cheaper |
|---|---|---|---|
| Month to month | $278 | — | only Ivim Health publishes this term |
| 3-month term | — | $209 | only HealthRX publishes this term |
| 12-month term | — | $179 | only HealthRX publishes this term |
| Settled dose | Ivim Health | HealthRX | Difference |
|---|---|---|---|
| 2.5 mg | $3,396 | $2,508 | $888 apart |
| 5 mg | — | $2,508 | one side unpriced |
| 7.5 mg | — | $2,508 | one side unpriced |
| 10 mg | $4,236 | $2,508 | $1,728 apart |
| 12.5 mg | — | $2,508 | one side unpriced |
| 15 mg | — | $2,508 | one side unpriced |
Ivim Health publishes no rate for 3-month term, 6-month term, 12-month term; HealthRX publishes none for month to month, 6-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,166 on Ivim Health and $2,508 on HealthRX — $1,658 apart, and a different gap from the $1,728 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Ivim Health publishes no price at 2 of the 6 doses, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 46.3 for Ivim Health and 82.1 for HealthRX, against a tirzepatide category floor of $169. HealthRX leads by 35.8 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Ivim Health | 33.5 | 12.8 | 0 | 0 | 46.3 |
| HealthRX | 56.6 | 10.5 | 10 | 5 | 82.1 |
Semaglutide
Plan pages: Ivim Health plans · HealthRX plans
At 2.4 mg/week, Ivim Health is $224 a month all-in and HealthRX is $133 — $91 apart, or $1,092 across a year. Over twelve months the totals are $2,688 (billed monthly) and $1,188 (prepaid term).
Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
HealthRX charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
HealthRX is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 53.1 for Ivim Health and 93.4 for HealthRX, against a semaglutide category floor of $129. HealthRX leads by 40.3 points, driven mostly by price.
Where the two programs differ
All-in monthly
HealthRX is cheaper month to month — $209 against $353, a gap of $144 every month, or $1,728 across a year if both rates hold.
Cancellation terms
Cancellation differs: Ivim Health states Cancel anytime, while HealthRX states Per provider terms; confirm at enrollment. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Ivim Health asks for Month-to-month; HealthRX asks for 12-month or 3-month plans only; no month-to-month rate published. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
HealthRX charges one price at every dose; Ivim Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Ivim Health's figure is provider-stated and HealthRX's is reported. Ivim Health rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Membership fee
Ivim Health charges a membership of $75 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Twelve-month cost
Over twelve months the totals are $4,236 for Ivim Health and $2,148 for HealthRX. HealthRX is lower by $2,088 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Ivim Health Official site
Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05
Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
HealthRX Official site
HealthRX offers flat per-dose compounded GLP-1 pricing on 12-month and 3-month commitment plans. Its $99/mo semaglutide and $179/mo tirzepatide on the twelve-month plan rank among the lowest annualized figures in the market. No month-to-month rate is published.
It does not publicly name its compounding pharmacy; the record shows healthrx.com (pharmacy partner not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are 12-month or 3-month plans only; no month-to-month rate published; cancellation is Per provider terms; confirm at enrollment; availability is stated as Confirm availability at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture verified 2026-07-18 on healthrx.com
Watch: HealthRX publishes no month-to-month rate; the $99/mo sema and $179/mo tirz are 12-month plan rates. The lowest commitment available is the 3-month plan ($133 sema, $209 tirz). Reported status — RangeYourself verified 2026-07-18 on healthrx.com; our independent checkout is pending.
What neither record tells you
Ivim Health does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says ~50 states
HealthRX does not publish
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm availability at intake
- no specific cancellation or refund terms
Ask Ivim Health and HealthRX for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. HealthRX carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. HealthRX publishes a twelve-month rate of $179 a month against $209 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, HealthRX Official site wins this matchup. If you expect to titrate to the top of the ladder, healthrx's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, healthrx carries no membership; and if you would rather trust a better-evidenced number, ivim health's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Ivim Health's tirzepatide price is provider-stated as of 2026-08-05; HealthRX's is reported as of 2026-07-18.
Questions
Is Ivim Health or HealthRX cheaper for tirzepatide?
HealthRX is cheaper on all-in monthly cost at 10 mg/week: $209 against $353, a difference of $144 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Ivim Health versus HealthRX?
Ivim Health works out to $4,236 across twelve months and HealthRX to $2,148, on the plan terms each publishes.
Does Ivim Health or HealthRX raise the price as the dose goes up?
Ivim Health: yes, it prices by dose. HealthRX: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Ivim Health and HealthRX differ?
7 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Ivim Health and HealthRX names its pharmacy?
Neither. Ivim Health records Partner pharmacies and HealthRX records healthrx.com (pharmacy partner not publicly named). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Ivim Health and HealthRX prices?
Ivim Health's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. HealthRX's is reported, captured 2026-07-18. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
HealthRX, at $133 a month all-in against $224 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Ivim Health official site · HealthRX official site. Compounded tirzepatide and semaglutide are not FDA-approved products.